[PDF][PDF] DNA-PKcs-mediated transcriptional regulation drives prostate cancer progression and metastasis
Emerging evidence demonstrates that the DNA repair kinase DNA-PKcs exerts divergent
roles in transcriptional regulation of unsolved consequence. Here, in vitro and in vivo …
roles in transcriptional regulation of unsolved consequence. Here, in vitro and in vivo …
[HTML][HTML] Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
…, CD Lallas, LG Gomella, WK Kelly, RC Birbe… - International Journal of …, 2014 - Elsevier
Purpose To test the hypothesis that a genomic classifier (GC) would predict biochemical
failure (BF) and distant metastasis (DM) in men receiving radiation therapy (RT) after radical …
failure (BF) and distant metastasis (DM) in men receiving radiation therapy (RT) after radical …
USP22 regulates oncogenic signaling pathways to drive lethal cancer progression
…, TJ Stanek, RT Sussman, JL Hicks, RC Birbe… - Cancer research, 2014 - AACR
Increasing evidence links deregulation of the ubiquitin-specific proteases 22 (USP22)
deubitiquitylase to cancer development and progression in a select group of tumor types, but its …
deubitiquitylase to cancer development and progression in a select group of tumor types, but its …
BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies
…, R Balliet, Z Lin, D Whitaker-Menezes, RC Birbe… - Cell cycle, 2012 - Taylor & Francis
Mutations in the BRCA1 tumor suppressor gene are commonly found in hereditary breast
cancer. Similarly, downregulation of BRCA1 protein expression is observed in the majority of …
cancer. Similarly, downregulation of BRCA1 protein expression is observed in the majority of …
Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4
Here, we developed a model system to evaluate the metabolic effects of oncogene(s) on the
host microenvironment. A matched set of “normal” and oncogenically transformed epithelial …
host microenvironment. A matched set of “normal” and oncogenically transformed epithelial …
[HTML][HTML] TP53-inducible glycolysis and apoptosis regulator (TIGAR) metabolically reprograms carcinoma and stromal cells in breast cancer
…, E Seifert, C Capparelli, M Tuluc, RC Birbe… - Journal of biological …, 2016 - ASBMB
A subgroup of breast cancers has several metabolic compartments. The mechanisms by
which metabolic compartmentalization develop in tumors are poorly characterized. TP53 …
which metabolic compartmentalization develop in tumors are poorly characterized. TP53 …
[HTML][HTML] MCT1 in invasive ductal carcinoma: monocarboxylate metabolism and aggressive breast cancer
…, Z Lin, T Zhan, M Tuluc, J Palazzo, RC Birbe… - Frontiers in cell and …, 2017 - frontiersin.org
Introduction: Monocarboxylate transporter 1 (MCT1) is an importer of monocarboxylates
such as lactate and pyruvate and a marker of mitochondrial metabolism. MCT1 is highly …
such as lactate and pyruvate and a marker of mitochondrial metabolism. MCT1 is highly …
TP53 Induced Glycolysis and Apoptosis Regulator and Monocarboxylate Transporter 4 drive metabolic reprogramming with c‐MYC and NFkB activation in breast …
…, Z Lin, D Whitaker‐Menezes, RC Birbe… - … Journal of Cancer, 2023 - Wiley Online Library
Breast cancer is composed of metabolically coupled cellular compartments with upregulation
of TP53 Induced Glycolysis and Apoptosis Regulator (TIGAR) in carcinoma cells and loss …
of TP53 Induced Glycolysis and Apoptosis Regulator (TIGAR) in carcinoma cells and loss …
Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease
…, P Li, BJ Stafford, EJ Faul, L Huang, RC Birbe… - Cancer research, 2009 - AACR
Cancer mucosa antigens are emerging as a new category of self-antigens expressed normally
in immunologically privileged mucosal compartments and universally by their derivative …
in immunologically privileged mucosal compartments and universally by their derivative …
Rosai-Dorfman disease in a patient with systemic lupus erythematosus.
PP Kaur, RC Birbe, RJ DeHoratius - The Journal of Rheumatology, 2005 - jrheum.org
Rosai-Dorfman disease (RDD), also known as sinus histocytosis with massive lymphadenopathy,
is a clinically benign, frequently chronic, painless lymphadenopathy. It can also …
is a clinically benign, frequently chronic, painless lymphadenopathy. It can also …